# FDA Warning Letter: Sichuan Deebio Pharmaceutical Co. Ltd.
> 2024-02-20 · Center for Drug Evaluation and Research | CDER · `cda78bb38b7b792b`
## Letter
- **Company:** Sichuan Deebio Pharmaceutical Co. Ltd.
- **Posted Date:** 2024-02-20
- **Letter Issue Date:** 2024-02-05
- **Issuing Office:** Center for Drug Evaluation and Research | CDER
## Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*